Research output per year

If you made any changes in Pure these will be visible here soon.

International and National Collaboration Publications and projects within past five years.


Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma

Weisel, K., Dimopoulos, M., Moreau, P., Yagci, M., Larocca, A., Kanate, A. S., Vural, F., Cascavilla, N., Basu, S., Johnson, P., Byeff, P., Hus, M., Rodriguez-Otero, P., Muelduer, E., Anttila, P., Hayden, P. J., Krauth, M-T., Lucio, P., Ben-Yehuda, D., Mendeleeva, L. & 6 others, Guo, S., Yu, X., Grote, L., Biyukov, T., Dhanasiri, S. & Richardson, P., 2 Jul 2020, In : Leukemia & lymphoma. 61, 8, p. 1850-1859 10 p.

Research output: Contribution to journalArticleScientificpeer-review

Associations between Microrna Expression, Disease Progression and Ex Vivo Drug Response in Multiple Myeloma

Kumari, R., Kumar, A., Parsons, A., Suvela, M., Lievonen, J., Silvennoinen, R., Anttila, P. & Heckman, C., 2019, In : Blood. 134, Supplement_1, 3069.

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Open Access

Monimuotoinen myelooma

Säily, M., Silvennoinen, R., Jantunen, E., Anttila, P., Lievonen, J. & Putkonen, M., 2019, In : Duodecim. 135, 12, p. 1171-1179 9 p.

Research output: Contribution to journalReview ArticleScientificpeer-review

Open Access

RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group

Luoma, S., Anttila, P., Säily, M., Lundan, T., Heiskanen, J., Siitonen, T., Kakko, S., Putkonen, M., Ollikainen, H., Terävä, V., Sankelo, M., Partanen, A., Launonen, K., Räsänen, A., Sikiö, A., Suominen, M., Bazia, P., Kananen, K., Lievonen, J., Selander, T. & 7 others, Pelliniemi, T-T., Ilveskero, S., Huotari, V., Mäntymaa, P., Tienhaara, A., Jantunen, E. & Silvennoinen, R., Dec 2019, In : Annals of Hematology. 98, 12, p. 2781-2792 12 p.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Real-world treatment outcomes in multiple myeloma: Multicenter registry results from Finland 2009-2013

Remes, K., Anttila, P., Silvennoinen, R., Putkonen, M., Ollikainen, H., Terävä, V., Sinisalo, M., Kananen, K., Schain, F., Castren-Kortegangas, P., Järvinen, T. M., Pisini, M., Wahl, F., Dixon, T. & Leval, A., 5 Dec 2018, In : PLoS One. 13, 12, 13 p., 0208507.

Research output: Contribution to journalArticleScientificpeer-review

Open Access

Press / Media

Minulla todettiin: Myelooma

Pekka Anttila


1 Media contribution

Press/Media: Press / Media